UNLIMITED

Weight Loss Medicine: GLP-1s

FromDocs Who Lift

Start listening View podcast show

UNLIMITED

Weight Loss Medicine: GLP-1s

FromDocs Who Lift

ratings:

Length:

44 minutes

Released:

Jul 11, 2022

Format:

Podcast episode

Description

Drs. Karl and Spencer discuss the most powerful medicines currently available for weight loss - the GLP-1s.
Learn:
How these medicines work
How much weight loss on average to expect from these medicine
The possible side effects and how to minimize them
Go to JoinSequence.com to see if you're eligible for one

Released:

Jul 11, 2022

Format:

Podcast episode

More Episodes from Docs Who Lift

Skip carousel

UNLIMITED
Debunking The Myths of Metabolism and Weight Loss: In this episode, Dr. Spencer and Dr. Karl sit down with Dr. Kevin Hall and Julia Belluz to break down the science behind metabolism, weight loss, and their new book Food Intelligence. They clear up the myths around the Biggest Loser study, explain why appetite biology matters more than a “broken metabolism,” and explore how our food environment, from ultra-processed diets to cultural norms, shapes health outcomes. by Docs Who Lift
58 min listen
UNLIMITED
Menopause Medicine Meets Obesity Care: Doctors React: Does menopausal hormone therapy change how women respond to GLP-1 medicines like tirzepatide and semaglutide? In this episode, Dr. Spencer Nadolsky and Dr. Karl Nadolsky sit down with Mayo Clinic’s Dr. Maria Daniela Hurtado Andrade and Dr. Regina Castaneda to discuss their latest research, the nuances behind the findings, and what it means for women navigating menopause and obesity care. Do you also want me to generate a few alternative title options that highlight their names (for authority) while still keeping the engagement factor? by Docs Who Lift
39 min listen
UNLIMITED
Women’s Fitness Needs Debate: Dr. Stacy Sims vs. Dr. Lauren Colenso-Semple: Do women really need to train and eat differently than men? In this episode, Dr. Stacy Sims and Dr. Lauren Colenso-Semple join Spencer and Karl for a spirited debate on fasted training, protein timing, perimenopause, and whether women’s unique physiology calls for unique fitness strategies. by Docs Who Lift
67 min listen
UNLIMITED
Do You Really Lose Muscle on Semaglutide or Tirzepatide?: Worried that GLP-1 medications like semaglutide or tirzepatide will make you lose muscle instead of fat? In this episode, we dive into real patient data, resistance training, and protein strategies to separate myth from reality. by Docs Who Lift
34 min listen
UNLIMITED
Predatory Lab Testing: What They’re Not Telling You: Some health companies are selling massive lab panels directly to consumers often with questionable medical value and zero real follow-up. We sit down with the Barbell Medicine crew to expose the risks, the marketing tactics, and the right way to approach lab testing without getting scammed. by Docs Who Lift
50 min listen
UNLIMITED
CVS Pulled the Plug on Zepbound?!: ChatGPT said: CVS Caremark just dropped Zepbound from its formulary, forcing countless patients to switch to Wegovy. In this episode, we break down why it happened, how PBMs are calling the shots, and what patients can actually do about it. by Docs Who Lift
20 min listen
UNLIMITED
More Than Weight Loss? GLP-1s and Cardiovascular Risk: Monjaro just dropped hot new trial results and they might show it helps you live longer. We break down the Surpass CVOT, compare it to Trulicity, and explain what this all means for your heart, kidneys, and overall health. by Docs Who Lift
11 min listen
UNLIMITED
Semaglutide vs. Tirzepatide: Are We Closing the Gap?: Can higher doses of semaglutide really deliver better results, without the side effects? In this episode of Docs Who Lift, Dr. Spencer Nadolsky and Dr. Karl Nadolsky Jr. sit down with Canadian obesity expert and clinical trialist Dr. Sean Wharton to break down the latest data from the STEP-UP trial. They dig into the science behind tripling the dose of semaglutide, how it compares to drugs like tirzepatide, and what it means for the future of obesity treatment. by Docs Who Lift
42 min listen
UNLIMITED
Clinical vs Anthropometric Obesity: Summary In this episode of the Docs Who Live podcast, Dr. Spencer Nadolsky and Dr. Karl Ndolsky Jr. engage with Dr. Jackie Yao and Dr. Michael Blaha from Johns Hopkins to discuss a recent study on obesity. They explore the definitions of clinical and anthropometric obesity, the challenges in classifying obesity, and the implications of the Lancet Commission's criteria. The conversation delves into the nuances of metabolic health, the importance of data sources, and future research directions in understanding obesity and its related health risks. by Docs Who Lift
32 min listen
UNLIMITED
GLP-1 meds and macular degeneration: Drs. Karl and Spencer talk to friend and retina specialist Dr. Eric Brugger about the new report of age-related macular degeneration along with an update on NAION. by Docs Who Lift
34 min listen
UNLIMITED
Menopause, MHT, and GLP-1 medicines: In this episode of the Docs Who Lift podcast, Drs. Karl and Spencer. welcome Dr. Beverly Tchang, an associate professor and obesity specialist at Cornell. The conversation delves into the complexities of menopausal hormonal therapy with GLP-1 medicine in women, and the impact of hormonal changes on weight loss. They discuss the nuances of hormonal replacement therapy, the influence of the wellness industry, and the importance of a holistic approach to women's health. Dr. Tchang shares insights from her recent post-hoc analysis on tirzepatide and its effects on women in different reproductive stages, emphasizing the need for more rigorous research in this area. by Docs Who Lift
28 min listen
UNLIMITED
The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass: In this episode of the Docs Who Lift podcast, Drs. Karl, Spencer, and Grant discuss the latest research on muscle growth, body composition, and the effects of GLP-1 receptor agonists. They delve into the role of myostatin in muscle regulation, the implications of recent trials on muscle mass loss, and the importance of exercise in maintaining muscle health. The conversation also touches on MRI data regarding muscle volume and the future of muscle-enhancing medications. by Docs Who Lift
28 min listen
UNLIMITED
Current State of Nutrition Research and MAHA: In this episode of the Docs Who Lift podcast, Dr. Spencer Nadolsky and Dr. Karl engage with Dr. Kevin Klatt to discuss the recent MAHA report and its implications for dietary guidelines and nutrition science. They explore the historical context of dietary guidelines, the challenges of funding nutrition research, and the political dynamics surrounding public health recommendations. The conversation highlights the disconnect between public perception and scientific evidence, as well as the need for a more robust investment in nutrition research to address chronic diseases and obesity. In this conversation, the speakers discuss the current state of food policy and nutrition science, highlighting the disconnect between political promises and actual changes in regulations. They critique the focus on superficial issues while neglecting more pressing health concerns, such as obesity and food safety. The conversation emphasizes the need for better by Docs Who Lift
56 min listen
UNLIMITED
Joy Prescriptions: Drs. Karl and Spencer talk to Dr. Tiffany Moon all about Joy Prescriptions. Learn how to stop chasing perfection and embrace connection. by Docs Who Lift
47 min listen
UNLIMITED
Zepbound versus Wegovy: In this episode of the Docs Who Lift podcast, Dr. Spencer Nadolsky and Dr. Karl discuss the latest findings from the SURMOUNT-5 on Zepbound (tirzepatide) vs. Wegovy (semaglutide,) two leading medications for weight loss and type 2 diabetes. They explore the efficacy, safety, and cost-effectiveness of these drugs, highlighting the significant weight loss outcomes associated with tirzepatide compared to semaglutide. The conversation also delves into the importance of patient stewardship in prescribing these medications, the impact of gender differences on weight loss results, and the need for more affordable options in the market. by Docs Who Lift
21 min listen
UNLIMITED
Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH).: In this episode, Spencer and Karl discuss a recent study on semaglutide for treating metabolic dysfunction associated steatotic liver disease (MASH). They explore the implications of the study, the Essence trial, and the potential of new treatments for obesity and liver health. The conversation also touches on the importance of early treatment and the need for more accessible medication options. by Docs Who Lift
22 min listen
UNLIMITED
Top 5 Women's Fitness Myths: Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women. by Docs Who Lift
37 min listen
UNLIMITED
GLP-1 and metabolism and depression: Drs. Karl and Spencer discuss a new study looking at tirzepatide and metabolic rate. They also discuss a patient case of tirzepatide induced anhedonia. by Docs Who Lift
25 min listen
UNLIMITED
Do GLP-1 meds cause more fat cells?: Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells. by Docs Who Lift
26 min listen
UNLIMITED
Future of medicine - Direct Care: Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care - the future of medicine. by Docs Who Lift
23 min listen
UNLIMITED
Tirzepatide and Muscle Loss with Dr. Grant Tinsley: Drs. Karl and Spencer discuss with Dr. Grant Tinsley all about the new analysis of how much "lean mass" is lost with tirzepatide, the most powerful medicine available for weight loss. by Docs Who Lift
28 min listen
UNLIMITED
The Super Bowl Hims and Hers Ad: Drs. Karl and Spencer discuss how bad the Hims and Hers ad was. by Docs Who Lift
25 min listen
UNLIMITED
NAD and NMN with Dr. Charles Brenner: Drs. Karl and Spencer chat with NAD metabolism expert Dr. Charles Brenner all about these supposed longevity supplements. by Docs Who Lift
39 min listen
UNLIMITED
The 60 Minutes Obesity Doctor - Dr. Fatima Cody Stanford: Drs. Karl and Spencer chat with Dr. Fatima Cody Stanford all about obesity, genetics, and her appearance on 60 minutes. by Docs Who Lift
46 min listen
UNLIMITED
New Obesity Definition and Higher Wegovy Dose: Drs. Karl and Spencer chat about the new Lancet Commission's report on Clinical Obesity along with the new study on high dosed Wegovy. by Docs Who Lift
29 min listen
UNLIMITED
The Ozempic Revolution - with Dr. Sowa: Drs. Karl and Spencer chat with Dr. Sowa about her book The Ozempic Revolution by Docs Who Lift
31 min listen
UNLIMITED
Microdosing GLP-1 and Cagrisema headlines: Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new topline results from REDEFINE which studied the new drug CagriSema. by Docs Who Lift
40 min listen
UNLIMITED
Changing your workouts based on your menstrual cycle: Drs. Karl and Spencer chat with Dr. Lauren Colenso-Semple all about how the menstrual cycle and how it should affect your workout programming. by Docs Who Lift
30 min listen
UNLIMITED
Zepbound vs Wegovy trial and compounded GLP-1s: Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s. by Docs Who Lift
44 min listen
UNLIMITED
Types of Diabetes, CGMs, and More: Drs. Karl and Spencer chat with Dr. Shivani Misra, a metabolic specialist physician researcher from the UK, all about the various forms of diabetes mellitus. by Docs Who Lift
66 min listen

Discover this podcast and so much more

Weight Loss Medicine: GLP-1s

Weight Loss Medicine: GLP-1s

Description

More Episodes from Docs Who Lift